Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Polyestradiol phosphate |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
Ethinylestradiol |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
Conjugated estrogen |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
Esterified estrogen |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
Dienestrol |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
Estradiol |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
Diethylstilbestrol diphosphate |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
Methallenestril |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
Estropipate |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
Methestrol (substance) |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
Benzestrol |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
Estrone |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
Estriol (substance) |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
Zeranol |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
Endometriosis of spermatic cord following estrogen therapy (disorder) |
Causative agent (attribute) |
False |
estrogeno |
Inferred relationship |
Some |
2 |
Accidental oestrogen poisoning |
Causative agent (attribute) |
False |
estrogeno |
Inferred relationship |
Some |
|
Intentional oestrogen poisoning |
Causative agent (attribute) |
False |
estrogeno |
Inferred relationship |
Some |
|
Estrogen poisoning of undetermined intent |
Causative agent (attribute) |
False |
estrogeno |
Inferred relationship |
Some |
1 |
Combined estrogen and progesterone poisoning of undetermined intent |
Causative agent (attribute) |
False |
estrogeno |
Inferred relationship |
Some |
|
Estrogen and progestogen preparation adverse reaction |
Causative agent (attribute) |
False |
estrogeno |
Inferred relationship |
Some |
2 |
Estrogen overdose |
Causative agent (attribute) |
False |
estrogeno |
Inferred relationship |
Some |
1 |
Accidental oestrogen overdose |
Causative agent (attribute) |
False |
estrogeno |
Inferred relationship |
Some |
1 |
Intentional estrogen overdose |
Causative agent (attribute) |
False |
estrogeno |
Inferred relationship |
Some |
1 |
Estrogen overdose of undetermined intent |
Causative agent (attribute) |
False |
estrogeno |
Inferred relationship |
Some |
1 |
Estrogen measurement, urine |
Has measured component (attribute) |
False |
estrogeno |
Inferred relationship |
Some |
|
Estrogen measurement |
Has measured component (attribute) |
False |
estrogeno |
Inferred relationship |
Some |
|
Estrogen measurement, urine |
Component |
False |
estrogeno |
Inferred relationship |
Some |
2 |
Estrogen measurement |
Component |
False |
estrogeno |
Inferred relationship |
Some |
1 |
Mestranol (substance) |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
Fosfestrol (substance) |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
Diethylstilbestrol (substance) |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
Estropipate 1.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
estrogeno |
Inferred relationship |
Some |
|
Product containing quinestradol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
estrogeno |
Inferred relationship |
Some |
|
Estradiol 2 mg and norethisterone acetate 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
estrogeno |
Inferred relationship |
Some |
|
Estradiol valerate 2 mg and norethisterone 700 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
estrogeno |
Inferred relationship |
Some |
|
Product containing precisely estradiol 1 milligram and norethisterone acetate 500 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
estrogeno |
Inferred relationship |
Some |
|
Estropipate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
estrogeno |
Inferred relationship |
Some |
|
Product containing hexestrol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
estrogeno |
Inferred relationship |
Some |
|
Chlorotrianisene preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
estrogeno |
Inferred relationship |
Some |
|
Estrogen receptor agonist-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
estrogeno |
Inferred relationship |
Some |
1 |
Non-steroidal estrogen preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
estrogeno |
Inferred relationship |
Some |
|
Estrogen-progestin preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
estrogeno |
Inferred relationship |
Some |
|
Steroidal estrogen preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
estrogeno |
Inferred relationship |
Some |
|
Combined oestogen+progestogen preparations |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
estrogeno |
Inferred relationship |
Some |
|
Menstrual disorder comb.preps |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
estrogeno |
Inferred relationship |
Some |
|
Estropipate 1.25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
estrogeno |
Inferred relationship |
Some |
|
Product containing precisely estropipate 625 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
estrogeno |
Inferred relationship |
Some |
|
Estropipate 750 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
estrogeno |
Inferred relationship |
Some |
|
Estropipate 3 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
estrogeno |
Inferred relationship |
Some |
|
Estropipate 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
estrogeno |
Inferred relationship |
Some |
|
Estropipate 1.5mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
estrogeno |
Inferred relationship |
Some |
|
Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
estrogeno |
Inferred relationship |
Some |
|
Product containing precisely esterified estrogen 625 microgram and methyltestosterone 1.25 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
estrogeno |
Inferred relationship |
Some |
|
Product containing precisely esterified estrogen 1.25 milligram and methyltestosterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
estrogeno |
Inferred relationship |
Some |
|
Levonorgestrel 125microgram / Ethinylestradiol 30microgram tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
estrogeno |
Inferred relationship |
Some |
|
Levonorgestrel 50microgram / Ethinylestradiol 30microgram tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
estrogeno |
Inferred relationship |
Some |
|
Conjugated estrogen 625 microgram and norgestrel 150 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
estrogeno |
Inferred relationship |
Some |
|
Levonorgestrel 75microgram / Ethinylestradiol 40microgram tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
estrogeno |
Inferred relationship |
Some |
|
Product containing chlorotrianisene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
estrogeno |
Inferred relationship |
Some |
|
Product containing piperazine estrone sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
estrogeno |
Inferred relationship |
Some |
|
Estrogens, conjugated+medroxyprogesterone acetate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
estrogeno |
Inferred relationship |
Some |
|
Product containing precisely conjugated estrogen 300 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
estrogeno |
Inferred relationship |
Some |
|
Product containing precisely conjugated estrogen 450 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
estrogeno |
Inferred relationship |
Some |
|
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
estrogeno |
Inferred relationship |
Some |
|
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
estrogeno |
Inferred relationship |
Some |
|
Urine oestrogen 24 hour assay |
Component |
False |
estrogeno |
Inferred relationship |
Some |
2 |
Implantation of estrogen implant (procedure) |
Direct substance |
False |
estrogeno |
Inferred relationship |
Some |
1 |
Quinestradol (substance) |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
Accidental combined estrogen and progesterone poisoning |
Causative agent (attribute) |
False |
estrogeno |
Inferred relationship |
Some |
1 |
Intentional combined estrogen and progesterone poisoning |
Causative agent (attribute) |
False |
estrogeno |
Inferred relationship |
Some |
2 |
Combined estrogen and progesterone poisoning of undetermined intent |
Causative agent (attribute) |
False |
estrogeno |
Inferred relationship |
Some |
1 |
Estrogen adverse reaction |
Causative agent (attribute) |
False |
estrogeno |
Inferred relationship |
Some |
1 |
Allergy to estrogen |
Causative agent (attribute) |
False |
estrogeno |
Inferred relationship |
Some |
|
Estrogen and progestogen preparation allergy |
Causative agent (attribute) |
False |
estrogeno |
Inferred relationship |
Some |
|
Poisoning caused by combined estrogen AND progestogen |
Causative agent (attribute) |
False |
estrogeno |
Inferred relationship |
Some |
2 |
Ovarian hormone poisoning NOS |
Causative agent (attribute) |
False |
estrogeno |
Inferred relationship |
Some |
|
Chlorotrianisene (substance) |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
Accidental oestrogen poisoning |
Causative agent (attribute) |
False |
estrogeno |
Inferred relationship |
Some |
1 |
Intentional oestrogen poisoning |
Causative agent (attribute) |
False |
estrogeno |
Inferred relationship |
Some |
1 |
Poisoning by estrogen |
Causative agent (attribute) |
False |
estrogeno |
Inferred relationship |
Some |
1 |
Implantation of estrogen implant (procedure) |
Direct substance |
False |
estrogeno |
Inferred relationship |
Some |
1 |
Allergy to estrogen |
Causative agent (attribute) |
False |
estrogeno |
Inferred relationship |
Some |
1 |
Promestriene |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
Albumin bound estradiol (substance) |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
Fosfestrol tetrasodium (substance) |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
Estrone sulfate |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
Estrone, unconjugated (substance) |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
Sodium estrone sulfate |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
Estradiol cypionate |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
Estradiol acetate (substance) |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
Estradiol hemihydrate |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
Estradiol enanthate (substance) |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
Free estradiol |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
Bioavailable estradiol |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
Estradiol benzoate |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
Estradiol valerate |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
2-hydroxyestrone |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
Estropipate |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
16 alpha-hydroxyestrone (substance) |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|
Quinestrol adverse reaction |
Causative agent (attribute) |
False |
estrogeno |
Inferred relationship |
Some |
2 |
Estriol, conjugated |
Is a |
False |
estrogeno |
Inferred relationship |
Some |
|